153 related articles for article (PubMed ID: 22860223)
1. Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators.
Ding C; Bremer NM; Smith TD; Seitz PK; Anastasio NC; Cunningham KA; Zhou J
ACS Chem Neurosci; 2012 Jul; 3(7):538-45. PubMed ID: 22860223
[TBL] [Abstract][Full Text] [Related]
2. Positive allosteric modulator of the human 5-HT2C receptor.
Im WB; Chio CL; Alberts GL; Dinh DM
Mol Pharmacol; 2003 Jul; 64(1):78-84. PubMed ID: 12815163
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT
Wild CT; Miszkiel JM; Wold EA; Soto CA; Ding C; Hartley RM; White MA; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2019 Jan; 62(1):288-305. PubMed ID: 29620897
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT
Wold EA; Garcia EJ; Wild CT; Miszkiel JM; Soto CA; Chen J; Pazdrak K; Fox RG; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2020 Jul; 63(14):7529-7544. PubMed ID: 32567857
[TBL] [Abstract][Full Text] [Related]
5. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
[TBL] [Abstract][Full Text] [Related]
6. Development of an improved IP(1) assay for the characterization of 5-HT(2C) receptor ligands.
Zhang JY; Kowal DM; Nawoschik SP; Dunlop J; Pausch MH; Peri R
Assay Drug Dev Technol; 2010 Feb; 8(1):106-13. PubMed ID: 19922239
[TBL] [Abstract][Full Text] [Related]
7. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
Dunlop J; Sabb AL; Mazandarani H; Zhang J; Kalgaonker S; Shukhina E; Sukoff S; Vogel RL; Stack G; Schechter L; Harrison BL; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2005 May; 313(2):862-9. PubMed ID: 15705738
[TBL] [Abstract][Full Text] [Related]
8. Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT
Singh K; Sona C; Ojha V; Singh M; Mishra A; Kumar A; Siddiqi MI; Tripathi RP; Yadav PN
Eur J Med Chem; 2019 Feb; 164():499-516. PubMed ID: 30622024
[TBL] [Abstract][Full Text] [Related]
9. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
[TBL] [Abstract][Full Text] [Related]
10. Validation of a selective serotonin 5-HT(2C) receptor antibody for utilization in fluorescence immunohistochemistry studies.
Bubar MJ; Seitz PK; Thomas ML; Cunningham KA
Brain Res; 2005 Nov; 1063(2):105-13. PubMed ID: 16274677
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
Andrews MD; Green MP; Allerton CM; Batchelor DV; Blagg J; Brown AD; Gordon DW; McMurray G; Millns DJ; Nichols CL; Watson L
Bioorg Med Chem Lett; 2009 Sep; 19(18):5346-50. PubMed ID: 19692241
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
13. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
[TBL] [Abstract][Full Text] [Related]
14. Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior.
Anastasio NC; Gilbertson SR; Bubar MJ; Agarkov A; Stutz SJ; Jeng Y; Bremer NM; Smith TD; Fox RG; Swinford SE; Seitz PK; Charendoff MN; Craft JW; Laezza FM; Watson CS; Briggs JM; Cunningham KA
J Neurosci; 2013 Jan; 33(4):1615-30. PubMed ID: 23345234
[TBL] [Abstract][Full Text] [Related]
15. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.
Anastasio NC; Lanfranco MF; Bubar MJ; Seitz PK; Stutz SJ; McGinnis AG; Watson CS; Cunningham KA
J Neurochem; 2010 Jun; 113(6):1504-15. PubMed ID: 20345755
[TBL] [Abstract][Full Text] [Related]
17. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.
Knauer CS; Campbell JE; Chio CL; Fitzgerald LW
Naunyn Schmiedebergs Arch Pharmacol; 2009 May; 379(5):461-71. PubMed ID: 19057895
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.
Cussac D; Newman-Tancredi A; Duqueyroix D; Pasteau V; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):578-89. PubMed ID: 12181434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
